Tetravalent influenza virus subunit vaccine（MDCK cell） (Changchun Institute Of Biological Products)

四价流感病毒亚单位疫苗（MDCK细胞）（长春生物）

Report date: 2023/08/22 10:06:36

Base Information

Drug NameTetravalent influenza virus subunit vaccine（MDCK cell） (Changchun Institute Of Biological Products)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Viral vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesChangchun Institute Of Biological Products Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChangchun Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A